Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE044A01036 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Sun Pharmaceut Sun Pharmaceutical Industries Ltd. | BSE 1730.15 0.80 (0.05%) | NSE 1728.90 0.90 (0.05%) | Trade | Add

BSE Live

Jan 05, 16:01

1730.15 0.80 (0.05%)

Volume

AVERAGE VOLUME

5-Day

44,911

10-Day

80,711

30-Day

82,766

131,178

Prev. Close

1729.35
Open Price

1716.60

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 05, 16:03

1728.90 0.90 (0.05%)

Volume

AVERAGE VOLUME

5-Day

1,544,078

10-Day

1,781,361

30-Day

1,985,439

1,416,698

Prev. Close

1728.00
Open Price

1728.00

Bid Price (Qty.)
1728.90 (400)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Sun Pharmaceutical Industries (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	52,041.25	47,758.45	43,278.87	38,426.42	33,139.18
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	52,041.25	47,758.45	43,278.87	38,426.42	33,139.18
Total Operating Revenues	52,578.44	48,496.85	43,885.68	38,654.49	33,498.14
Other Income	1,965.04	1,354.19	634.52	921.51	835.52
Total Revenue	54,543.48	49,851.04	44,520.20	39,576.00	34,333.66
EXPENSES
Cost Of Materials Consumed	6,449.10	6,904.33	7,777.57	7,049.12	6,153.13
Purchase Of Stock-In Trade	4,147.95	3,466.15	3,571.50	3,410.03	3,175.17
Operating And Direct Expenses	0.00	630.26	561.32	557.81	0.00
Changes In Inventories Of FGWIP And Stock In Trade	150.31	292.13	-686.91	-107.61	-638.22
Employee Benefit Expenses	9,973.12	9,429.06	8,296.03	7,300.83	6,862.23
Finance Costs	231.36	238.47	172.00	127.35	141.43
Depreciation And Amortisation Expenses	2,575.39	2,556.64	2,529.43	2,143.74	2,079.95
Other Expenses	16,586.27	14,751.79	12,719.38	10,046.59	9,454.46
Total Expenses	40,113.50	38,268.83	34,940.32	30,527.86	27,228.15
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	14,429.98	11,582.21	9,579.88	9,048.14	7,105.51
Exceptional Items	-677.85	-494.32	-171.45	-4,566.82	-4,306.14
Profit/Loss Before Tax	13,752.13	11,087.89	9,408.43	4,481.32	2,799.37
Tax Expenses-Continued Operations
Current Tax	3,320.05	1,989.30	1,869.22	354.39	957.30
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-548.02	-549.85	-1,021.63	721.11	-442.61
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	2,772.03	1,439.45	847.59	1,075.50	514.69
Profit/Loss After Tax And Before ExtraOrdinary Items	10,980.10	9,648.44	8,560.84	3,405.82	2,284.68
Profit/Loss From Continuing Operations	10,980.10	9,648.44	8,560.84	3,405.82	2,284.68
Profit/Loss For The Period	10,980.10	9,648.44	8,560.84	3,405.82	2,284.68
Minority Interest	-35.71	-33.65	-39.36	-116.55	631.47
Consolidated Profit/Loss After MI And Associates	10,929.04	9,576.38	8,473.58	3,272.73	2,903.82
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	46.00	40.00	35.00	14.00	12.00
Diluted EPS (Rs.)	46.00	40.00	35.00	14.00	12.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	3,613.97	2,898.16	2,519.30	2,158.91	1,559.06
Tax On Dividend	0.00	0.00	0.00	0.00	0.00